ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 110 filers reported holding ENZO BIOCHEM INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,961,000 | -31.6% | 763,219 | -27.8% | 0.04% | -40.3% |
| Q1 2018 | $5,789,000 | -34.0% | 1,056,400 | -1.9% | 0.07% | -39.0% |
| Q4 2017 | $8,772,000 | -14.6% | 1,076,312 | +9.7% | 0.12% | -18.1% |
| Q3 2017 | $10,271,000 | -7.0% | 981,007 | -1.9% | 0.14% | -11.7% |
| Q2 2017 | $11,040,000 | +58.7% | 999,961 | +20.3% | 0.16% | +39.3% |
| Q1 2017 | $6,958,000 | +21.7% | 831,354 | +0.9% | 0.12% | +3.5% |
| Q4 2016 | $5,718,000 | +28.8% | 823,953 | -5.5% | 0.11% | +48.7% |
| Q3 2016 | $4,439,000 | -12.8% | 872,009 | +2.3% | 0.08% | -24.8% |
| Q2 2016 | $5,089,000 | +165.1% | 852,438 | +102.0% | 0.10% | +165.8% |
| Q1 2016 | $1,920,000 | +10.3% | 422,043 | +9.1% | 0.04% | +35.7% |
| Q4 2015 | $1,740,000 | – | 386,723 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |